Saturday, October 3, 2020

Dr Reddy#39;s launches generic version of Sapropterin Dihydrochloride tablets in US market

Dr Reddy#39;s launches generic version of Sapropterin Dihydrochloride tablets in US market This product demonstrates that the company is actively expanding the breadth of its portfolio with a treatment for a rare disease, he added.

from Moneycontrol Business News https://ift.tt/2GyssYC

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...